ECM
IMNM icon

ExodusPoint Capital Management’s Immunome IMNM Stock Holding History

ExodusPoint Capital Management’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.52M Sell
115,370
-664,208
-85% -$14.8M 0.02% 683
2025
Q4 		$16.7M Buy
+779,578
New +$13.7M 0.13% 132
2025
Q3 		– Sell
-81,873
Closed -$761K – 1761
2025
Q2 		$761K Sell
81,873
-20,280
-20% -$166K 0.01% 1042
2025
Q1 		$687K Buy
+102,153
New +$980K 0.01% 1024
2024
Q2 		– Sell
-34,991
Closed -$864K – 1726
2024
Q1 		$864K Buy
34,991
+1,849
+6% +$37.5K 0.01% 994
2023
Q4 		$355K Buy
+33,142
New +$276K ﹤0.01% 1128
2021
Q3 		– Sell
-12,800
Closed -$221K – 2360
2021
Q2 		$221K Buy
+12,800
New +$283K ﹤0.01% 1918

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

ExodusPoint Capital Management's IMNM Position: Q1 2026 in Review

ExodusPoint Capital Management reduced its Immunome (IMNM) stake by 85% in Q1 2026, selling an estimated $14.8M and leaving 115,370 shares worth $2.52M. The position accounts for 0.02% of the portfolio, ranked #683.

ExodusPoint Capital Management first reported a position in IMNM in Q2 2021 and has held it in 7 quarters since. The position peaked at $16.7M in Q4 2025. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • ExodusPoint Capital Management held 115,370 shares of Immunome worth $2.52M as of Q1 2026.
  • ExodusPoint Capital Management sold 664,208 Immunome shares in Q1 2026, an estimated $14.8M.
  • Immunome made up 0.02% of ExodusPoint Capital Management's portfolio in Q1 2026, its #683 holding.
  • ExodusPoint Capital Management first reported a position in Immunome in Q2 2021 and has held it in 7 quarters since.
  • ExodusPoint Capital Management's Immunome position peaked at $16.7M in Q4 2025.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.